{
    "Trade/Device Name(s)": [
        "AnemoCheck"
    ],
    "Submitter Information": "Sanguina, LLC",
    "510(k) Number": "K163215",
    "Predicate Device Reference 510(k) Number(s)": [
        "K032203",
        "K042251"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KHG"
    ],
    "Summary Letter Date": "July 13, 2017",
    "Summary Letter Received Date": "July 14, 2017",
    "Submission Date": "September 7, 2017",
    "Regulation Number(s)": [
        "21 CFR 864.7500"
    ],
    "Regulation Name(s)": [
        "Whole blood hemoglobin assays"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobin",
        "Hematocrit"
    ],
    "Specimen Type(s)": [
        "Whole blood",
        "Capillary blood",
        "Venous blood"
    ],
    "Specimen Container(s)": [
        "K2EDTA tube",
        "Heparin tube",
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Colorimetric assay"
    ],
    "Methodologies": [
        "Semi-quantitative assay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for AnemoCheck semi-quantitative colorimetric assay to measure hemoglobin and estimate hematocrit in anticoagulated whole blood.",
    "Indications for Use Summary": "In vitro diagnostic semi-quantitative assay for determination of hemoglobin level and estimation of hematocrit percentage in anticoagulated (K2EDTA, heparin, citrate) whole blood from capillary or venous samples; not for neonatal samples (birth\u20131 month).",
    "fda_folder": "Hematology"
}